Acute kidney injury and adverse renal events in patients receiving SGLT2-inhibitors: A systematic review and meta-analysis

Review of 121 studies concludes despite reports of adverse effects associated with hypovolaemia, SGLT2s reduce the odds of suffering acute kidney injury with and without hospitalisation as shown in randomised trials and the real-world setting.

Source:

PLOS Medicine